본문 바로가기
KERD
논문KCI 등재

소아에서 내시경 검사의 출혈 위험 예측 인자로서 혈액 응고 검사 및 혈소판 검사의 의의

Clinical Significance of Coagulation Screening Tests and Platelet Counts in Children Undergoing Endoscopy

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류소아과학

초록

Purpose: The aim of this study was to assess the benefits of routine pre-endoscopy coagulation screening tests and platelet counts in Korean children. Methods: Between March 2004 and December 2009, children who underwent gastrointestinal endoscopy for the evaluation of various gastrointestinal symptoms were included. All of the subjects included in the study also underwent routine coagulation screening and platelet count determinations prior to endoscopy and biopsy. The clinical records and laboratory tests were retrospectively reviewed in all patients. Results: One hundred sixty-two of 1,476 (11%) patients who underwent endoscopy had abnormal results on pre-screening coagulation tests. Fourteen patients underwent coagulation factor assays due to abnormal clotting results in consecutive tests or due to clinical evidence of a bleeding tendency. Seven patients were diagnosed with factor XII deficiency, one patient was diagnosed with von Willebrand disease, one patient had von Willebrand disease and factor XII deficiency, and one patient was presumed to have mild hemophilia. The remaining 4 patients had normal results with the factor assays. The results of platelet counts were normal with the exception of 1 patient. No patient had significant bleeding during the endoscopic procedures, despite abnormal pre-endoscopic coagulation tests. Conclusion: Routine coagulation screening tests and platelet counts revealed abnormal results in some patients. Most of the patients with abnormal clotting were shown to have a factor XII deficiency, which had no significant associated bleeding tendencies; the other patients were diagnosed with hemophilia or von Willebrand disease. Therefore, although abnormal pre-endoscopic coagulation is not always related to significant bleeding complications, pre-endoscopic coagulation screening may be useful in some children in predicting the risk of bleeding tendency during endoscopic procedures. (Korean J Pediatr Gastroenterol Nutr 2010; 13: 23∼29)

Abstract

Purpose: The aim of this study was to assess the benefits of routine pre-endoscopy coagulation screening tests and platelet counts in Korean children. Methods: Between March 2004 and December 2009, children who underwent gastrointestinal endoscopy for the evaluation of various gastrointestinal symptoms were included. All of the subjects included in the study also underwent routine coagulation screening and platelet count determinations prior to endoscopy and biopsy. The clinical records and laboratory tests were retrospectively reviewed in all patients. Results: One hundred sixty-two of 1,476 (11%) patients who underwent endoscopy had abnormal results on pre-screening coagulation tests. Fourteen patients underwent coagulation factor assays due to abnormal clotting results in consecutive tests or due to clinical evidence of a bleeding tendency. Seven patients were diagnosed with factor XII deficiency, one patient was diagnosed with von Willebrand disease, one patient had von Willebrand disease and factor XII deficiency, and one patient was presumed to have mild hemophilia. The remaining 4 patients had normal results with the factor assays. The results of platelet counts were normal with the exception of 1 patient. No patient had significant bleeding during the endoscopic procedures, despite abnormal pre-endoscopic coagulation tests. Conclusion: Routine coagulation screening tests and platelet counts revealed abnormal results in some patients. Most of the patients with abnormal clotting were shown to have a factor XII deficiency, which had no significant associated bleeding tendencies; the other patients were diagnosed with hemophilia or von Willebrand disease. Therefore, although abnormal pre-endoscopic coagulation is not always related to significant bleeding complications, pre-endoscopic coagulation screening may be useful in some children in predicting the risk of bleeding tendency during endoscopic procedures. (Korean J Pediatr Gastroenterol Nutr 2010; 13: 23∼29)

참고문헌 (29)

  1. Levy MJ, "Position statement on routine laboratory testing before endoscopic procedures", Gastrointest Endosc, 68, pp.827~832 (2008)
  2. Ettingshausen CE, "Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors", Thromb Haemostasis, 85, pp.218~220 (2001)
  3. Ljung R, "Diagnostic symptoms of severe and moderate haemophilia A and B a survey of 140 cases", Acta paediatrica, 79, pp.196~200 (1990)
  4. Pollmann H, "When are children diagnosed as having severe haemophilia and when do they start to bleed? A 10-year single-centre PUP study", Eur J Pediatr, 158, pp.166~170 (1999)
  5. Kitchens CS, "Occult hemophilia", Johns Hopkins Med J, 146, pp.255~259 (1980)
  6. Venkateswaran L, "Mild hemophilia in children: prevalence, complications and treatment", J Pediatr Hematol Oncol, 20, pp.32~ (1998)
  7. Van Os EC, "Gastroenterological procedures among patients with disorders of hemostasis: evaluation and management recommendations", Gastrointest Endosc, 50, pp.536~543 (1999)
  8. Andrew M, "Maturation of the hemostatic system during childhood", Blood, 80, pp.1998~2005 (1992)
  9. Andrew M, "Development of the human coagulation system in the full-term infant", Blood, 70, pp.165~172 (1987)
  10. Dzik WH, "Predicting hemorrhage using preoperative coagulation screening assays", Curr Hematol Rep, 3, pp.324~330 (2004)
  11. Suchman AI, "How well does the activated partial thromboplastin time predict postoperative hemorrhage?", JAMA, 256, pp.750~753 (1986)
  12. Rohrer MJ, "A prospective evaluation of the efficacy of preoperative coagulation testing", Ann Surg, 208, pp.554~557 (1988)
  13. Perez A, "Value of routine preoperative tests: a multicentre study in four general hospitals", Br J Anaesth, 74, pp.250~256 (1995)
  14. Smetana GW, "The case against routine preoperative laboratory testing", Med Clin North Am, 87, pp.7~40 (2003)
  15. Giles E, "Routine coagulation screening in children undergoing gastrointestinal endoscopy does not predict those at risk of bleeding", Endoscopy, 38, pp.508~510 (2006)
  16. Burk CD, "Preoperative history and coagulation screening in children undergoing tonsillectomy", Pediatrics, 89, pp.691~695 (1992)
  17. Lowe GD, "Laboratory diagnosis of congenital coagulation defects", Clin Haematol, 8, pp.79~94 (1979)
  18. Dzankic S, "The prevalence and predictive value of abnormal preoperative laboratory tests in elderly surgical patients", Anesth Analg, 93, pp.301~308 (2001)
  19. 용동은, "제 X II 응고인지 결핍증 1예", 한국지혈혈전학회지, 3, pp.145~151 (1996)
  20. Stavrou E, "Factor XII: What does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis", Thrombosis Research, 125, pp.210~215 (2010)
  21. Mannhalter C, "Factor XII activity and antigen concentrations in patients suffering from recurrent thrombosis", Fibrinolysis, 1, pp.259~263 (1987)
  22. 남윤성, "반복자연유산에서 12번 응고인자 결핍증에 대한 연구", 대한불임학회지, 28, pp.209~213 (2001)
  23. 남윤성, "반복자연유산 환자에서 발견된 응고인자 12 부족증 1례", 대한불임학회지, 26, pp.271~274 (1999)
  24. Gordon EM, "Reduced titers of Hageman factor (factor XII) in Orientals", Ann Intern Med, 95, pp.697~700 (1981)
  25. 조영욱, "정상 한국인 집단과 허혈성 뇌혈관질환 환자군에서의 응고인자 XII 46C", T 다형성 분석, 2002, pp.22(4), 224~231[DOI]
  26. Halbmayer WM, "The prevalence of moderate and severe Fxii (Hageman-Factor) deficiency among the normal population - evaluation of the incidence of Fxii deficiency among 300 healthy blood- donors", Thromb Haemostasis, 71, pp.68~72 (1994)
  27. Barthels M, "Additional factor XII (Hageman factor) deficiency in hemophilia A and in von Willebrand syndrome", J Mol Med, 60, pp.303~309 (1982)
  28. Rodeghiero F, "Epidemiological investigation of the prevalence of von Willebrand's disease", Blood, 69, pp.454~459 (1987)
  29. Sadler JE, "Impact, diagnosis and treatment of von Willebrand disease", Thromb Haemost, 84, pp.160~174 (2000)

관련 논문AI추천

이 간행물의 다른 논문 (12건)